24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
specialties & services
Dr. Timothy Campbell graduated from the Indiana University School of Medicine. He also did a residency and a fellowship in hematology and oncology, both at the University of California, San Francisco. He is a board-certified medical oncologist and currently practices at several hospitals such as the St. Mary’s Medical Center, California Pacific Medical Center, Kaiser Permanente San Francisco Medical Center, and UCSF Medical Center. Dr. Campbell has also contributed to several research publications.
Indiana University
Medical School
UCSF
Residency
UCSF
Fellowship
American Board of Internal Medicine - Oncology
California Pacific Medical Center
Languages: English/Spanish
(415) 600-6000
Castro St & Duboce Ave
San Francisco, California 94114 
Kaiser Permanente San Francisco Medical Center
Languages: English/Spanish
(415) 833-2000
2238 Geary Blvd
San Francisco, California 94115
San Francisco General Hospital
Languages: English/Spanish
(415) 206-8000
1001 Potrero Ave
San Francisco, California 94110
San Francisco VA Medical Center
Languages: English/Spanish
(415) 221-4810
4150 Clement St
San Francisco, California 94121
St. Luke's Hospital
Languages: English/Spanish
(415) 600-6000
3555 Cesar Chavez
San Francisco, California 94110
St. Mary's Medical Center - San Francisco
Languages: English/Spanish
(415) 668-1000
450 Stanyan St
San Francisco, California 94117
UCSF Medical Center
Languages: English/Spanish
(415) 353-1037
505 Parnassus Ave
San Francisco, California 94143
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities.
Schepers K Campbell TB Passegue E; Cell Stem Cell. 2015 Mar 5 .
See more >>
Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis.
Broxmeyer HE Hoggatt J O'Leary HA Mantel C Chitteti BR Cooper S Messina-Graham S Hangoc G Farag S Rohrabaugh SL Ou X Speth J Pelus LM Srour EF Campbell TB; Nat Med. 2012 Dec .
See more >>
Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice.
Rohrabaugh SL Campbell TB Hangoc G Broxmeyer HE; Blood Cells Mol Dis. 2011 Apr 15 .
See more >>
Hospitals & Clinics
